News
AI-powered WhatsApp messaging cleared for NHS pilot
An artificial intelligence-driven WhatsApp messaging platform for …
19731 items found
News
TIGIT developer iTeos raises $120m, and other financings
Our round-up of notable biotech financings in the last week includes …
Patients
Patient safety signals in non-traditional channels: AI and NLP uncover critical information
The clinical research industry has experienced a seismic shift over …
Patients
Conference report: Reuters Pharma Europe
In this special edition of the pharmaphorum podcast, the tables have …
Sales & Marketing
Sponsored
12 Questions with Kirsten Parr
Kirsten Parr heads up CMC Connect, a division of IPG Health Medical …
News
Roche trumpets potential ‘best-in-class’ obesity drug
Roche has reported early clinical data with its candidate obesity …
R&D
FT US Pharma and Biotech Summit: Live coverage
This week, pharmaphorum heads to the Big Apple for the FT US Pharma …
News
FDA clears BMS’ Breyanzi for follicular lymphoma
Bristol-Myers Squibb has chalked up another FDA approval for its …
News
GSK, UK govt put £130m into antimicrobial resistance fight
GSK has become the first founding partner of the new Fleming …
News
Updated BIOSECURE Act draft clears House committee
Legislation that would restrict US organisations from contracting …
News
Uniquity Bio emerges with $300m for MSD immunology drug
New start-up Uniquity Bio arrived on the scene today with $300 …
R&D
Partner Content
3rd mRNA Process Development & Manufacturing Summit
Your Roadmap for mRNA Process Development & Manufacturing with …
News
GSK plans $800m US manufacturing investment
GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
LSX 2024 - Dr Tadaaki Taniguchi
At LSX in Boston last month, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some r
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
Patients
Partner Content
How walking in a patient's shoes adds value to your patient ...
Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?
